Event Content

As the demand for temperature-sensitive pharmaceuticals continues to rise, the need for efficient, compliant, and sustainable cold chain packaging has never been more critical. This discussion will explore how the pharmaceutical industry is navigating the complex landscape of regulatory compliance while al...

The presentation explores the rapidly growing biologics market and addresses poor accessibility challenges through breakthrough solutions, including an ultra-large scale production line, innovative manufacturing processes featuring Epic-CHO® Cell Line and Grand-CHO® Platform, and revolutionary Panflex®-Eng...

In this session, presenters will discuss challenges and explore potential solutions associated with establishing robust and resilient vaccine manufacturing and supply chains in low- and middle-income countries (LMICs). While these regions face significant constraints in manufacturing capabilities and suppl...

In the pharmaceutical industry, packaging is evolving from a simple protective function to a powerful tool for consumer engagement. Smart, connected packaging technologies are transforming how consumers interact with pharma products, offering personalized experiences, real-time health information, and enha...

Pennsylvania is at the forefront of Biologics innovations. To fully realize its potential, the state and industry requires robust collaboration with academia. Universities and research institutions have a vital role to play, from cultivating talent and driving research to fostering technology transfer and ...

Discover the ROTOTHERM® MINI, Artisan Industries' newest innovation in thin-film evaporation technology - and your new R&D tool. This lab-scale evaporator offers a continuous, scalable, and cost-effective solution for R&D teams looking to enhance their separation processes while preserving product quality....

This panel brings together experts to discuss the latest technological breakthroughs revolutionizing advanced bio-manufacturing. From AI-driven automation to cutting-edge bioprocessing tools, we’ll examine how these innovations are enhancing scalability, precision, and efficiency in biologics production. ...

Every four years, a new administration brings changes that can significantly impact the pharmaceutical supply chain. From regulatory shifts and trade policies to public health funding and drug pricing reforms. These policy shifts not only affect supply chain resilience but also shape access to life-saving ...

Device reusability has gained increasing attention in recent years, owing toits potential to reduce both the costs and environmental impact of drug delivery devices. This has made reusable autoinjectors an appealing and potentially more sustainable option, especially when considering chronic conditions whi...

Do we understand the true reality of what someone who isn't a Healthcare Professional goes through when they open the packaging and prepare to use a medical device in an emergency? After decades of feeding into the design and development of these devices, I was unfortunately one of those people. If I hadn’...

We have ready capacity, when you need it. • For our Pharma-, Diagnostics- and MedTec customers we build ahead according to their future needs and scale-up scenarios. • See our recent growth case studies and learn how we can secure your program success and speed up your time-to-market. MGS is your com...

Delve into the future of vaccination technology as market experts Moderna unveil the potential of mRNA vaccines to revolutionise healthcare. Don't miss this opportunity to explore the forefront of medical innovation and discover how these next-generation vaccines are reshaping the landscape of disease pre...

The European Union faces a growing challenge in securing its supply of essential pharmaceuticals. Currently, the majority of its active pharmaceutical ingredients (APIs) and finished medicines are imported from Asia, with China being the largest single supplier. This heavy reliance on external sources has ...

Despite the frequent claims that collaboration is the key to sustainability, very little proactive collaboration is apparent. This presentation will detail how true collaboration and action is possible, and how an Industry as a whole can deliver change and mobilise towards improved End of Life for its pac...

The evolving landscape of the pharmaceutical industry, marked by significant breakthroughs in advanced treatments and relentless pressures for speed and innovation, has fundamentally transformed the role of Contract Development and Manufacturing Organizations (CDMOs). As the industry faces challenges from ...

How can we become truly patient-centric? This session will explore strategies for deeper collaboration between big pharma and patients, set against the backdrop of an evolving healthcare landscape where patient voices are key to innovation. Explore dynamic pathways for incorporating patient insights int...

Exploring the growing role of 3D printing in pharmaceutical manufacturing, including personalized medication and dosage forms - Pharmaceutical 3D printing is a rapidly growing field, with more and more research groups in academia and industry investing time and resources to investigate its use to personali...

Bioproduction in the US pharmaceutical industry is crucial for delivering life-saving medications efficiently. Advancements in biotechnology and rising demand are driving rapid evolution in bioproduction. While state-of-the-art facilities and strict regulations define the sector, challenges in scalability,...

Antibody-drug conjugates (ADCs) are pioneering biologics that merge antibodies’ specificity with small molecules’ potency. With a handful of FDA-approved ADCs in the market and many under development, ADCs are poised to revolutionize therapeutics. This talk examines the complexities of ADC production, emph...

Towards a circular economy within the healthcare sector: What are the challenges? There is a fast-increasing awareness regarding the high environmental impact of our healthcare sector and the consequences it has. There is an urgent need for collaborative initiatives to reduce the environmental impact of...

Bormioli Pharma has developed a solid and extensive patient-centric innovation program intended to advise the pharma industry along the entire drug development process, from early stage compatibility assessment up to the production of parts needed for drug fileing, clinical trials and commercialization. ...

This session will explore: • The role of the device supplier in overall product sustainability • Benefits of lifecycle assessment (LCA) in device development • Trade-offs between usability, cost of goods, and carbon footprint • Challenging Pharma to close the circle and enable better solutions

After years of investment in R&D, pharmaceutical companies have brought to the market a growing number of new therapies based on mRNA or viral vector technology, which require storage at freezing temperatures. Deep cold storage poses great challenges to the primary packaging container. This session will ...

Though viral vectors are used extensively in cell and gene therapy, the challenges of manufacturing such complex biologics at industrial scale is still a limitation to its broader use.
Dr. Ayuso will speak about how upstream and downstream process optimization using design of experiments (DOE), a p...

BSI – set the scene of the challenge of manufacturing antibiotics and the environment - 3 mins
Centrient – what we have done so far to invest in mitigating environmental threat?– 5 mins BSI – One Health approach towards setting industry standard and certification for combatting antibiotics dischar...

The complexity and risks found within the global pharma supply chain cannot be understated and key stakeholders from customers to regulators, and investors are increasingly expecting the industry to both manage ESG risks and embed sustainability throughout the value chain.
This can only be achieved ...

Where QBD was the orchestral sheet music that determined how drug product development has been harmonized over the last 15 or so years, contemporary patient-centric risk-based approaches to drug development are the pop evolution. The music is still beautiful when produced well - but the focus is no longer...

Join our case study to learn more about the current supply chain set-up across the industry and gain takeaways on how to reduce your environmental footprint: • How does the PSCI make a positive impact towards the creation of sustainable supply chains? • Audit Program • Capability Building ...

Pharmaceutical and other healthcare innovations have extended and improved countless lives in recent decades. Today, advanced manufacturing technologies such as pharmaceutical continuous manufacturing are gaining increasing interest for their potential to serve as one more way to improve global health by b...

Companies must have the right partner to avoid potential setbacks in clinical development. To avoid disappointment, join our panel and gain expert analysis and best practices in sourcing the right CDMO for your study: • Strategies for getting the most out of our CDMO partnership – mapping objectives, d...

Packaging is an integral part of the design for pharmaceutical products and medical devices. Not only does one need to take into account the look, feel, and protective qualities of the packaging but design must be considered when determining the sterilization technology. Determining the sterilization techn...

Our healthcare industry is evolving. The move from IV to SC injection is being driven by lifecycle management, biosimilar adoption, and the hospital to home trend. Molecules are getting more complex, and patients drive the preference for self-administration resulting in the need for more complex combinatio...

Advances in auto-injector design now provide the option to use both 1ml and 2.25mL syringes plus employ technology to adapt to varying fill volumes and viscosities all whilst maintaining the same device form. This provides a solution for the formulation changes that take place during drug development, clin...

We at Körber believe the pharmaceutical industry will ultimately dispense of plastic packaging within a few years. Our Rondo Solutions are pioneering when it comes to sustainability. Today pharmaceutical packaging expects to be innovative, compact, safe, and environmentally friendly. That’s because opin...

More than 75 % of new chemical entities are poorly soluble and require bioavailability-enhancing excipients. The application of excipients in advanced pharmaceutical processes, such as hot melt extrusion and 3D-printing, aligned with advanced approaches towards personalized medicine, requires special featu...

In Dec 2021, Thermo Fisher completed the acquisition of PPD, Inc, a leading global provider of clinical research services to the biopharma and biotech industry. With the addition of PPD, Thermo Fisher will offer a comprehensive suite of world-class services across the clinical development spectrum – from s...

• Digitalization in biopharma is more complex than just replacing paper documents with electronic counterparts or hiring data scientist • In the context of bioprocessing, the industry needs a better way to transition quickly from lab to clinical to commercial manufacturing • Speed to clinic require...

According to the WHO, “Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments.”

Unfortunately, many of the available interventions are cumbersome, inaccessible and or too expensive...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Dr. Robert Lindner, Global Product Manager RTU Vials, SCHOTT AG will discuss how sterile integrity is indispensable in aseptic fill-and-finish operations. Pharmaceutical companies pay highest attention to producing high quality d...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Felix Georg Müller, CEO & Co-Founder, plus10 GmbH introduces the company's innovative and GMP-compliant AI-tools for automated pharmaceutical production and packaging lines. The focus of the presentation is a detailed best practic...

In this webinar, originally part of Pharmapack Europe 2022, Thomas Watts, Engineering Consultant, Team Consulting discusses tackling the challenges of cloud connectivity. The electronic Product Information initiative for Medicines (ePI) aim to ease the accessibility on product information to everyone with...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, Isabelle Jenny, Sustainability Manager, Amcor in collaboration with Healthcare Plastics Recycling Council (HPRC) discusses as consumers awareness and demand continues to grow, switching to sustainable packaging materials and practic...

In this webinar, originally broadcast as part of CPHI North America, Marrisa Fayer, Ceo and Founder HerHealthEQ discusses in this session: • Where women are needed more (hint, it's everywhere) • Why having women involved in all aspects of the business makes better business • How to get more women i...

In this webinar, originally broadcast as a part of Pharmapack Europe 2022, speaker Nigel Langley, Director Technical Service & Scientific Affairs, BASF Pharma Solutions reviews the 'Novel Excipient Review Pilot Program'. Launched at the end of 2021, the voluntary Novel Excipient Review Pilot Program (Pilot...

The webinar addresses the need for new modalities, evolution of bio manufacturing of new modalities, and comparison with semiconductor manufacturing. This session was broadcast as part of the CPHI North America show.

Outsourcing drug manufacturing is a common solution to building manufacturing capacity among drug sponsors. Developing appropriate oversight for CDMO’s is key to a successful product launch. This session will discuss key responsibilities for drug sponsors in overseeing their providers, including which r...